Standard BioTools Inc. (LAB) Financials

$1.78

north_east
$0.05 (2.6%)
Day's range
$1.69
Day's range
$1.79

LAB Income statement / Annual

Last year (2023), Standard BioTools Inc.'s total revenue was $106.34 M, an increase of 8.57% from the previous year. In 2023, Standard BioTools Inc.'s net income was -$74.66 M. See Standard BioTools Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $106.34 M $97.95 M $130.58 M $138.14 M $117.24 M $112.96 M $101.94 M $104.45 M $114.71 M $116.46 M
Cost of Revenue $55.89 M $60.90 M $61.21 M $54.82 M $52.96 M $51.32 M $49.96 M $46.01 M $46.63 M $42.85 M
Gross Profit $50.45 M $37.05 M $69.37 M $83.33 M $64.28 M $61.65 M $51.98 M $58.44 M $68.08 M $73.61 M
Gross Profit Ratio 0.47 0.38 0.53 0.6 0.55 0.55 0.51 0.56 0.59 0.63
Research and Development Expenses $25.95 M $38.50 M $37.94 M $36.46 M $31.64 M $30.03 M $30.83 M $38.42 M $39.26 M $43.42 M
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $87.54 M $114.76 M $98.89 M $97.90 M $84.48 M $79.78 M $79.52 M $93.21 M $82.96 M $71.32 M
Other Expenses $13.56 M -$12.31 M $7.63 M $507,000.00 $1.43 M $637,000.00 $385,000.00 -$1.17 M -$1.16 M -$857,000.00
Operating Expenses $127.05 M $153.26 M $136.83 M $134.36 M $116.12 M $109.81 M $110.34 M $131.63 M $122.22 M $114.75 M
Cost And Expenses $182.94 M $214.15 M $198.04 M $189.18 M $169.08 M $161.13 M $160.30 M $177.64 M $168.85 M $157.60 M
Interest Income $0.00 $4.33 M $291,000.00 $307,000.00 $1.33 M $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $4.57 M $4.33 M $3.82 M $3.57 M $4.28 M $13.89 M $5.82 M $5.82 M $5.81 M $5.34 M
Depreciation & Amortization $15.18 M $15.03 M $16.07 M $17.94 M $15.81 M $16.50 M $18.30 M $17.94 M $16.12 M $4.06 M
EBITDA -$54.46 M -$173.57 M -$43.77 M -$34.61 M -$46.62 M -$31.03 M -$39.68 M -$56.42 M -$32.87 M -$38.50 M
EBITDA Ratio -0.51 -1.16 -0.34 -0.25 -0.3 -0.27 -0.39 -0.54 -0.34 -0.33
Operating Income Ratio -0.72 -1.19 -0.52 -0.37 -0.44 -0.43 -0.57 -0.7 -0.44 -0.45
Total Other Income/Expenses Net $2.40 M -$76.72 M $3.80 M -$3.07 M -$14.87 M -$13.26 M -$5.44 M -$6.99 M -$4.64 M -$5.87 M
Income Before Tax -$74.20 M -$192.93 M -$63.66 M -$54.10 M -$66.71 M -$61.42 M -$63.80 M -$80.18 M -$54.79 M -$57.71 M
Income Before Tax Ratio -0.7 -1.97 -0.49 -0.39 -0.57 -0.54 -0.63 -0.77 -0.48 -0.5
Income Tax Expense $452,000.00 -$2.83 M -$4.42 M -$1.08 M -$1.92 M -$2.41 M -$3.26 M -$4.19 M -$1.48 M -$4.88 M
Net Income -$74.66 M -$190.10 M -$59.24 M -$53.02 M -$64.79 M -$59.01 M -$60.54 M -$75.99 M -$53.32 M -$52.83 M
Net Income Ratio -0.7 -1.94 -0.45 -0.38 -0.55 -0.52 -0.59 -0.73 -0.46 -0.45
EPS -0.94 -2.43 -0.78 -0.74 -0.97 -1.49 -1.84 -2.62 -1.86 -1.9
EPS Diluted -0.94 -2.43 -0.78 -0.74 -0.97 -1.49 -1.84 -2.62 -1.86 -1.9
Weighted Average Shares Out $79.16 M $78.31 M $75.79 M $72.04 M $66.78 M $39.65 M $32.98 M $29.01 M $28.71 M $27.77 M
Weighted Average Shares Out Diluted $79.16 M $78.31 M $75.79 M $72.04 M $66.78 M $39.65 M $32.98 M $29.01 M $28.71 M $27.77 M
Link